Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Asperlicin: a unique nonpeptide cholecystokinin antagonist.

Zucker KA, Adrian TE, Zdon MJ, Ballantyne GH, Modlin IM.

Surgery. 1987 Aug;102(2):163-70.

PMID:
2441481
2.

Effect of L364718, a new CCK antagonist, on amylase secretion in isolated rat pancreatic acini.

Hosotani R, Chowdhury P, McKay D, Rayford PL.

Pancreas. 1988;3(1):95-8.

PMID:
2452436
3.

A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus.

Chang RS, Lotti VJ, Monaghan RL, Birnbaum J, Stapley EO, Goetz MA, Albers-Schönberg G, Patchett AA, Liesch JM, Hensens OD, et al.

Science. 1985 Oct 11;230(4722):177-9.

PMID:
2994227
4.

Properties of receptors for gastrin and CCK on gastric smooth muscle cells.

Menozzi D, Gardner JD, Jensen RT, Maton PN.

Am J Physiol. 1989 Jul;257(1 Pt 1):G73-9.

PMID:
2473654
5.

Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility.

Bock MG, DiPardo RM, Rittle KE, Evans BE, Freidinger RM, Veber DF, Chang RS, Chen TB, Keegan ME, Lotti VJ.

J Med Chem. 1986 Oct;29(10):1941-5.

PMID:
3761313
6.

Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.

Louie DS, Liang JP, Owyang C.

Am J Physiol. 1988 Sep;255(3 Pt 1):G261-6.

PMID:
2458681
7.

A novel micromethod for pancreatic acinar secretion. Time course of CCK stimulation and its inhibition by L-364,718.

Adrian TE, Zucker KA, Bilchik AJ, Modlin IM.

Int J Pancreatol. 1990 Jan;6(1):61-9.

PMID:
1700032
8.

Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.

Niederau M, Niederau C, Strohmeyer G, Grendell JH.

Am J Physiol. 1989 Jan;256(1 Pt 1):G150-7.

PMID:
2463767
10.

Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.

Huang SC, Zhang L, Chiang HC, Wank SA, Maton PN, Gardner JD, Jensen RT.

Am J Physiol. 1989 Jul;257(1 Pt 1):G169-74.

PMID:
2473653
11.

A synthetic peptide derivative that is a cholecystokinin receptor antagonist.

Lignon MF, Galas MC, Rodriguez M, Laur J, Aumelas A, Martinez J.

J Biol Chem. 1987 May 25;262(15):7226-31.

12.

Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).

Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF Jr, Wagenaar F, Nadzan AM.

Mol Pharmacol. 1989 Dec;36(6):881-6.

PMID:
2601685
13.
14.

Structural features of various proglumide-related cholecystokinin receptor antagonists.

Jensen RT, Zhou ZC, Murphy RB, Jones SW, Setnikar I, Rovati LA, Gardner JD.

Am J Physiol. 1986 Dec;251(6 Pt 1):G839-46.

PMID:
2431626
15.

Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.

Otsuki M, Fujii M, Nakamura T, Okabayashi Y, Tani S, Fujisawa T, Koide M, Baba S.

Dig Dis Sci. 1989 Jun;34(6):857-64.

PMID:
2470557
16.

Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini.

Pollo DA, Baldassare JJ, Honda T, Henderson PA, Talkad VD, Gardner JD.

Biochim Biophys Acta. 1994 Oct 20;1224(1):127-38.

PMID:
7524684
17.
18.

Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.

Otsuki M, Fujii M, Nakamura T, Okabayashi Y, Tani S, Fujisawa T, Koide M, Baba S.

Digestion. 1989;42(2):61-9.

PMID:
2475379
19.

In vitro and in vivo effect of proglumide on cholecystokinin-stimulated amylase release in mouse pancreatic acini.

Iwamoto Y, Nakamura R, Akanuma Y.

Gastroenterol Jpn. 1984 Feb;19(1):53-8.

PMID:
6202584
20.

Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.

Makovec F, Bani M, Cereda R, Chisté R, Pacini MA, Revel L, Rovati LA, Rovati LC, Setnikar I.

Arzneimittelforschung. 1987 Nov;37(11):1265-8.

PMID:
3440035

Supplemental Content

Support Center